BioCentury
ARTICLE | Company News

Durect, NeuroSystec Corp. deal

June 28, 2004 7:00 AM UTC

DRRX granted NeuroSystec exclusive worldwide rights to develop and market treatments for inner ear disorders using DRRX's drug delivery technologies. DRRX received an upfront fee and is eligible for m...